Bio-Gene Total Revenue from 2010 to 2025
| BGT Stock | 0.03 0 10.00% |
Total Revenue | First Reported 2013-12-31 | Previous Quarter 18.8 K | Current Value (435.00) | Quarterly Volatility 112.1 K |
Check Bio-Gene Technology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio-Gene Technology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.4 K, Interest Expense of 63.8 K or Selling General Administrative of 1.7 M, as well as many indicators such as . Bio-Gene financial statements analysis is a perfect complement when working with Bio-Gene Technology Valuation or Volatility modules.
Bio-Gene | Total Revenue |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bio-Gene Stock Analysis
When running Bio-Gene Technology's price analysis, check to measure Bio-Gene Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Gene Technology is operating at the current time. Most of Bio-Gene Technology's value examination focuses on studying past and present price action to predict the probability of Bio-Gene Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Gene Technology's price. Additionally, you may evaluate how the addition of Bio-Gene Technology to your portfolios can decrease your overall portfolio volatility.